DE2806199A1 - Aminopyrimidinverbindungen, verfahren zu ihrer herstellung und arzneimittel - Google Patents

Aminopyrimidinverbindungen, verfahren zu ihrer herstellung und arzneimittel

Info

Publication number
DE2806199A1
DE2806199A1 DE19782806199 DE2806199A DE2806199A1 DE 2806199 A1 DE2806199 A1 DE 2806199A1 DE 19782806199 DE19782806199 DE 19782806199 DE 2806199 A DE2806199 A DE 2806199A DE 2806199 A1 DE2806199 A1 DE 2806199A1
Authority
DE
Germany
Prior art keywords
carbon atoms
formula
compound
substituted
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19782806199
Other languages
German (de)
English (en)
Inventor
Jun Davis L Temple
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DE2806199A1 publication Critical patent/DE2806199A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE19782806199 1977-02-14 1978-02-14 Aminopyrimidinverbindungen, verfahren zu ihrer herstellung und arzneimittel Withdrawn DE2806199A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76829177A 1977-02-14 1977-02-14

Publications (1)

Publication Number Publication Date
DE2806199A1 true DE2806199A1 (de) 1978-08-17

Family

ID=25082078

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782806199 Withdrawn DE2806199A1 (de) 1977-02-14 1978-02-14 Aminopyrimidinverbindungen, verfahren zu ihrer herstellung und arzneimittel

Country Status (22)

Country Link
JP (1) JPS53103497A (fi)
AR (1) AR229078A1 (fi)
AT (1) AT363948B (fi)
AU (1) AU519271B2 (fi)
BE (1) BE863525A (fi)
CS (1) CS207499B2 (fi)
DD (1) DD138211A5 (fi)
DE (1) DE2806199A1 (fi)
DK (1) DK60578A (fi)
ES (1) ES466981A1 (fi)
FI (1) FI64598C (fi)
FR (1) FR2380282A1 (fi)
GB (1) GB1596320A (fi)
GR (1) GR72456B (fi)
HU (1) HU182460B (fi)
IE (1) IE46456B1 (fi)
IL (1) IL54037A (fi)
NO (1) NO780504L (fi)
PH (1) PH14777A (fi)
SE (2) SE7801637L (fi)
YU (4) YU40578A (fi)
ZA (1) ZA78870B (fi)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT386826B (de) * 1984-12-22 1988-10-25 Krka Tovarna Zdravil Verfahren zur herstellung von 9-(2hydroxy|thoxymethyl) -guanin

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE195739T1 (de) * 1989-10-20 2000-09-15 Kyowa Hakko Kogyo Kk Kondensierte purinderivate
IL98559A0 (en) * 1990-06-21 1992-07-15 Schering Corp Polycyclic guanine derivatives
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
US7772232B2 (en) 2004-04-15 2010-08-10 Bristol-Myers Squibb Company Quinazolinyl compounds as inhibitors of potassium channel function
EP2044074A2 (en) 2006-06-23 2009-04-08 Incyte Corporation Purinone derivatives as hm74a agonists

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT386826B (de) * 1984-12-22 1988-10-25 Krka Tovarna Zdravil Verfahren zur herstellung von 9-(2hydroxy|thoxymethyl) -guanin

Also Published As

Publication number Publication date
CS207499B2 (en) 1981-07-31
ATA106778A (de) 1981-02-15
HU182460B (en) 1984-01-30
YU40578A (en) 1983-04-30
GR72456B (fi) 1983-11-09
FR2380282A1 (fr) 1978-09-08
YU198682A (en) 1983-04-30
PH14777A (en) 1981-12-09
GB1596320A (en) 1981-08-26
IE780310L (en) 1978-08-14
DK60578A (da) 1978-08-15
YU198782A (en) 1983-04-30
AR229078A1 (es) 1983-06-15
SE7801637L (sv) 1978-08-15
AU519271B2 (en) 1981-11-19
AT363948B (de) 1981-09-10
YU198882A (en) 1983-04-30
IL54037A0 (en) 1978-04-30
JPS53103497A (en) 1978-09-08
BE863525A (fr) 1978-07-31
NO780504L (no) 1978-08-15
AU3322178A (en) 1979-08-23
ES466981A1 (es) 1979-08-16
ZA78870B (en) 1979-01-31
SE8301408L (sv) 1983-03-15
IE46456B1 (en) 1983-06-15
FI64598B (fi) 1983-08-31
FR2380282B1 (fi) 1982-03-05
SE8301408D0 (sv) 1983-03-15
IL54037A (en) 1982-02-28
FI780427A (fi) 1978-08-15
DD138211A5 (de) 1979-10-17
FI64598C (fi) 1983-12-12

Similar Documents

Publication Publication Date Title
DE68913831T2 (de) Kondensierte Pyrimidinderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE3884304T2 (de) Piperazinylderivate von Purinen und deren Isostere als hypoglykämische Wirkstoffe.
DE3685608T2 (de) 8-phenylxanthine.
DE2822544C2 (fi)
DE2818676A1 (de) Substituierte 5,6-dimethylpyrrolo 2,3-d pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3011490A1 (de) 4-amino-3-chinolincarbonsaeure und derivate davon, verfahren zur herstellung dieser verbindungen und ihreverwendung
WO1982003626A1 (en) New derivatives of pyrazolo(3,4-d)pyrimidine,preparation method thereof and remedy containing them
DE69732413T2 (de) Verfahren zur synthese chemischer verbindungen mit pde-iv-hemmender wirkung
DE2257547A1 (de) Pyrazolo eckige klammer auf 1,5a eckige klammer zu -pyrimidine
DD139855A5 (de) Verfahren zur herstellung von xanthinderivaten
DE2713389C2 (fi)
DD242407A5 (de) Verfahren zur herstellung von imidazoderivaten
DD158776A5 (de) Verfahren zur herstellung von di-oder triesubstituiertenxanthinen
DE2424334A1 (de) Verfahren zur herstellung neuer heterocyclischer verbindungen
EP0880524B1 (de) Adenosin-antagonisten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DD142048A5 (de) Verfahren zur herstellung von substituierten 2-phenylimino-imidazolidinen
DD149066A5 (de) Benzazepin-derivate
DE2133998A1 (de) 2,3-dihydro-oxo-imidazo eckige klammer auf 1,2-a eckige klammer zu -pyrimidine, deren saeureadditionssalze und verfahren zu deren herstellung
DE2806199A1 (de) Aminopyrimidinverbindungen, verfahren zu ihrer herstellung und arzneimittel
DE1809013A1 (de) Verfahren zur Herstellung heterocyclischer Verbindungen sowie neue Heterocycloimidazole
EP0132811A1 (de) In 1-Stellung substituierte 4-Hydroxymethyl-pyrrolidinone, Verfahren zu ihrer Herstellung, pharmazeutische Zusammensetzungen und Zwischenprodukte
DE3445299A1 (de) Neue imidazoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CH639661A5 (de) 3-(1-piperazinyl)-pyrido(2.3-b)pyrazine.
DE2913295A1 (de) 4-oxo-4h-pyrido eckige klammer auf 1,2-a eckige klammer zu pyrimidin-3-n- (1h-tetrazol-5-yl)carboxamide, verfahren zu deren herstellung und pharmazeutisches mittel
DE2630469C2 (de) 6-Alkoxy-N-(5-tetrazolyl)-1-oxo-1H-pyrimido-[1,2-a] chinolin-2-carboxamide, Verfahren zu deren Herstellung und dieselben enthaltende antiallergisch wirksame pharmazeutische Zubereitungen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8139 Disposal/non-payment of the annual fee